TMO invests in innovative new products and expanded capabilities to further enhance its unique customer value proposition. It launched a number of new products...
JNJ received EU approval for PONVORY in relapsing multiple sclerosis and also a U.S. approval of RYBREVANT for the treatment of patients with locally...
The acquisition of Caelyx , Doxil rights strengthens Pharmaceuticals portfolio globally and, in particular, represents a platform to accelerate growth in Europe for BAX....
Quest Diagnostics incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such...
OMCL has adopted three legged strategy which includes market expansion through innovative products and solutions, expansion into new markets (outside US) and expansion through...
Takeda’s world class R&D engine is fueled by leveraging internal research capabilities and actively engaging with innovative ecosystems around the world. This efficient R&D...
Evergreen Therapeutics, Inc. announced a clinical service agreement with ICON plc in Jun – 21. The agreement aims to conduct a global, multi center...
RCM and Mednax announced partnership agreement in May – 21. The agreement will bolster the overall patient experience and optimize clinical, financial and operational...
TXG acquired Copenhagen, Denmark based T cell detection startup Tetramer Shop in Feb 21. Tetramer Shop will enable TXG’s customers to accelerate the development...
The core competencies and resources developed over the last decade by the company has helped in development of first approved mRNA vaccine against COVID...
Boutique equity research firm providing Business, Investment and M&A research services focused on fast growing Technology, Healthcare, Life science and Industrial sectors.